Exelfos | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Summary of the safety profile: The most common adverse reactions following the single-dose administration of Fosfomycin trometamol involve the gastrointestinal tract, mainly diarrhea. These events are usually self-limited in duration and resolve spontaneously.
Tabulated list of adverse reactions: The following table displays adverse reactions that have been reported with the use of Fosfomycin trometamol from either clinical-trial or post-marketing experiences.
Undesirable effects are listed by body system and frequency using the following convention: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated form the available data).
Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. (See Table 2.)

Click on icon to see table/diagram/image

View ADR Reporting Link

Exelfos Adverse Reactions

fosfomycin

Manufacturer:

Exeltis

Distributor:

DKLL

Marketer:

Exeltis